{"id":"W4243694231","doi":"10.1093/annonc/mdv050.06","title":"A Randomized, Double-Blind, Phase 2 Trial of Veliparib (ABT-888) with Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Veliparib; Carboplatin; Internal medicine; PARP inhibitor; Lung cancer; Neutropenia; Oncology; Clinical endpoint; Gastroenterology; Randomized controlled trial; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002460612,0.002839624,0.004051774,0.0006803118,0.0006872513,0.001573864,0.001554954,0.002378798,0.008867235],"category_scores_gemma":[0.002293311,0.001522934,0.001780725,0.0006043587,0.002213275,0.002045075,0.0006928351,0.00486491,0.001904157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009703583,"about_ca_system_score_gemma":0.001793655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009925654,"about_ca_topic_score_gemma":0.002126245,"domain_scores_codex":[0.9990253,0.0005100986,0.00005091633,0.0002152365,0.00005104857,0.000147307],"domain_scores_gemma":[0.9988486,0.0003244857,0.0001934223,0.0001376615,0.00005696175,0.0004389891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836821,0.007338739,0.0001607084,0.0001892321,0.0002666763,0.00001755571,0.00002884736,0.0002556811,0.001566402,0.00007719146,0.0004215424,0.005995368],"study_design_scores_gemma":[0.9735568,0.02538747,0.0002646254,0.000006475004,0.00008625043,0.00001226062,0.000008019381,0.0002326917,0.0001517324,0.0000850284,0.0002012306,0.000007508824],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819797,0.002238109,0.001211381,0.0008359532,0.001087553,0.007926668,0.001458638,0.0003076767,0.002954222],"genre_scores_gemma":[0.9740317,0.002052666,0.003340235,0.001605705,0.0007657619,0.01039772,0.001932755,0.00009076765,0.005782667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008867235,"threshold_uncertainty_score":0.02966386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1672549693496572,"score_gpt":0.4600048391791383,"score_spread":0.292749869829481,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}